Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedAug 9, 2017Ibuprofen TabletsPresence of foreign tablets/capsules: Ibuprofen Tablets USP, 600 mg bottles were found to contain some Ibuprofen Tablets USP 800 mg.Time-Cap Laboratories, Inc. · D-1055-2017Class IITerminatedAug 9, 2017Magnesium Citrate Oral SolutionMicrobial contamination of non-sterile products: product was found to contain mold, identified as Rhinocladiella similis.Vi-Jon, Inc. · D-1054-2017Class IITerminatedAug 9, 2017Lactulose SolutionMicrobial contamination of non-sterile product: product failed Total Yeast/Mold Count specification.VistaPharm, Inc. · D-1053-2017Class IITerminatedAug 9, 2017Lactulose SolutionMicrobial contamination of non-sterile product: product failed Total Yeast/Mold Count specification.VistaPharm, Inc. · D-1052-2017Class IITerminatedAug 9, 2017Alka-Seltzer GoldDefective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.Bayer HealthCare Pharmaceuticals, Inc. · D-1051-2017Class IITerminatedAug 9, 2017Alka-Seltzer Extra StrengthDefective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.Bayer HealthCare Pharmaceuticals, Inc. · D-1050-2017Class IITerminatedAug 9, 2017Neut Sodium Bicarbonate 4%Lack of Sterility AssuranceHospira a Pfizer Company · D-1049-2017Class IITerminatedAug 9, 2017Succinylcholine Chloride InjectionLack of Sterility AssuranceHospira a Pfizer Company · D-1048-2017Class IITerminatedAug 9, 20178.4% Sodium Bicarbonate InjLack of Sterility AssuranceHospira a Pfizer Company · D-1047-2017Class IITerminatedAug 9, 2017Potassium Phosphates InjLack of Sterility AssuranceHospira a Pfizer Company · D-1046-2017Class IITerminatedAug 9, 2017Alka-Seltzer OriginalDefective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.Bayer HealthCare Pharmaceuticals, Inc. · D-1044-2017Class IITerminatedAug 9, 2017Divalproex Sodium Delayed Release TabletsFailed Dissolution SpecificationsZydus Pharmaceuticals USA Inc · D-1043-2017Class IITerminatedAug 9, 2017Divalproex Sodium Delayed Release TabletsFailed Dissolution SpecificationsZydus Pharmaceuticals USA Inc · D-1042-2017Class IITerminatedAug 9, 2017Divalproex Sodium Delayed Release TabletsFailed Dissolution SpecificationsZydus Pharmaceuticals USA Inc · D-1041-2017Class IITerminatedAug 9, 2017Testosterone Cypionate + ProgesteroneCGMP DeviationsFusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical · D-1040-2017Class IIITerminatedAug 9, 2017Albuterol Sulfate Inhalation SolutionFailed Impurities/Degradation Specifications: high out of specification results for related compound D.Teva Pharmaceuticals USA · D-1039-2017Class IIITerminatedAug 9, 2017Pravastatin Sodium TabletsFailed Impurities/Degradation Specifications: high out of specification results for related impurity for lot C700220.Dr. Reddy's Laboratories, Inc. · D-1038-2017Class IITerminatedAug 9, 2017Carbamazepine Oral SuspensionLabeling Error: Label mix-up. Products' unit dose cups are correctly labeled, but the product carton lists incorrect volume and NDC.Precision Dose Inc. · D-1037-2017Class IITerminatedAug 9, 2017Cyclobenzaprine HCl TabletsLabeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mgApace KY LLC · D-1036-2017Class IITerminatedAug 9, 2017Amantadine HCl CapsulesLabeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mgApace KY LLC · D-1035-2017Class IITerminatedAug 2, 2017fentaNYL 2 mcg/mL + Ropivacaine 0.2% PF in NS 250 mLLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1034-2017Class IITerminatedAug 2, 2017Potassium Chloride 40 meq Added to Sodium Chloride 0.9% 250 mLLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1033-2017Class IITerminatedAug 2, 2017Potassium Chloride 20 meq Added to Sodium Chloride 0.9% 250 mLLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1032-2017Class IITerminatedAug 2, 2017PHENYLephrine 50 mg in 0.9% Sodium Chloride 250 mLLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1031-2017Class IITerminatedAug 2, 2017PHENYLephrine 20 mg in 0.9% Sodium Chloride 250 mL BagLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1030-2017Class IITerminatedAug 2, 2017PHENYLephrine 200 mg in 0.9% Sodium Chloride 250 mLLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1029-2017Class IITerminatedAug 2, 2017PHENYLephrine 100 mg in 0.9% Sodium Chloride 250 mL BagLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1028-2017Class IITerminatedAug 2, 2017PHENYLephrine 40 mg in 0.9% Sodium Chloride 250 mLLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1027-2017Class IITerminatedAug 2, 2017PHENYLephrine 10 mg in 0.9% Sodium Chloride 250 mL bagLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1026-2017Class IITerminatedAug 2, 2017PHENYLephrine HCl 10 mg in 0.9% Sodium Chloride 250 mL BagLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1025-2017Class IITerminatedAug 2, 2017PHENYLephrine HCl 25 mg in 0.9% Sodium Chloride 250 mLLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1024-2017Class IITerminatedAug 2, 2017PHENYLephrine HCl 60 mg in 0.9% Sodium Chloride 250 mLLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1023-2017Class IITerminatedAug 2, 2017NORepinephrine Bitartrate 16 mg in 0.9% Sodium Chloride 250 mL from StockLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1022-2017Class IITerminatedAug 2, 2017NORepinephrine Bitartrate 8 mg in 0.9% Sodium Chloride 250 mLLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1021-2017Class IITerminatedAug 2, 2017NORepinephrine 4 mg in 0.9% Sodium Chloride 250 mL from StockLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1020-2017Class IITerminatedAug 2, 2017EPINEPHrine HCl 4 mg in 0.9% Sodium Chloride 250 mLLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1019-2017Class IITerminatedAug 2, 2017ePHEDrine Sulfate 5 mg/mL in NS 5 mL Fill in 12 mL SyringeLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1018-2017Class IITerminatedAug 2, 2017Hydromorphone 0.5 mg/mL in 0.9% Sodium Chloride 1 mL Fill in 3 mL BD syringeLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1017-2017Class IITerminatedAug 2, 2017fentaNYL 3 mcg/mL + BUPIvacaine 0.1% in 0.9% Sodium Chloride 250 mLLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1016-2017Class IITerminatedAug 2, 2017fentaNYL 2 mcg/mL + BUPIvacaine 0.125% PF in 0.9% Sodium Chloride 250 mLLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1015-2017